FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/063469 [Registered on: 01/03/2024] Trial Registered Prospectively
Last Modified On: 02/06/2024
Post Graduate Thesis  No 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Identifying the genetic background of neurological disorders related to the mitochondrial DNA repair pathway 
Scientific Title of Study   Delineating the genomic basis of neurodegeneration and mitochondrial disorders associated with defective DNA break repair 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
IEC1:78/2023  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sanjiban Chakrabarty 
Designation  Associate Professor 
Affiliation  Manipal School of Life Sciences 
Address  2nd floor,Department of cell and molecular biology,Manipal School of Life Sciences,MAHE,Manipal,Karnataka,India

Udupi
KARNATAKA
576104
India 
Phone  9986297508  
Fax  0  
Email  sanjiban.c@manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sanjiban Chakrabarty 
Designation  Associate Professor 
Affiliation  Manipal School of Life Sciences 
Address  2nd floor,Department of cell and molecular biology,Manipal School of Life Sciences,MAHE,Manipal,Karnataka,India

Udupi
KARNATAKA
576104
India 
Phone  9986297508  
Fax  0  
Email  sanjiban.c@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Dr Sanjiban Chakrabarty 
Designation  Associate Professor 
Affiliation  Manipal School of Life Sciences 
Address  2nd floor,Department of cell and molecular biology,Manipal School of Life Sciences,MAHE,Manipal,Karnataka,India

Udupi
KARNATAKA
576104
India 
Phone  9986297508  
Fax  0  
Email  sanjiban.c@manipal.edu  
 
Source of Monetary or Material Support  
Department of Health Research (DHR), India.  
Manipal School of Life Science, MAHE, Manipal 
 
Primary Sponsor  
Name  Sanjiban Chakrabarty 
Address  2nd floor, Department of Cell and Molecular Biology Manipal School of Life Sciences Manipal Academy of Higher Education Manipal 576104 Karnataka, INDIA Office: 91 820 2922058, Mobile: 9986297508  
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sanjiban Chakrabarty  Manipal School of Life Sciences  2nd floor, Department of cell and molecular biology, Manipal School of Life Sciences, MAHE, MANIPAL, KARNATAKA, INDIA
Udupi
KARNATAKA 
09986297508
0
sanjiban.c@manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: G300||Alzheimers disease with early onset, (2) ICD-10 Condition: G309||Alzheimers disease, unspecified, (3) ICD-10 Condition: G31||Other degenerative diseases of nervous system, not elsewhere classified, (4) ICD-10 Condition: G328||Other specified degenerative disorders of nervous system in diseases classified elsewhere,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  1.00 Month(s)
Age To  65.00 Year(s)
Gender  Both 
Details  1. Individuals with clinical features, radiological findings, and biochemical analysis suggestive of a mitochondrial disorder using Mitochondrial Disease Criteria(Score more than 5).
2. Clinical presentation – Motor developmental delay, myopathy, dystonia, ataxia, seizures, exercise intolerance, spasticity, growth failure, hearing and vision impairment, cardiomyopathy, gastrointestinal issues. 
 
ExclusionCriteria 
Details  1. Individuals having a score of less than 5 utilizing mitochondrial disease criteria(MDC) regardless of age of onset or presentation.
2. Participate with non-genetic disorders, such as autoimmune or inflammatory infections, endocrine or hypoxic insults in the neonatal period, medications, or toxins exposure  
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
We aim to gain insights into the impact of disturbed DNA replication and repair on mitochondrial DNA maintenance, which could inform the development of targeted interventions to mitigate the effects of these conditions.  We aim to gain insights into the impact of disturbed DNA replication and repair on mitochondrial DNA maintenance, which could inform the development of targeted interventions to mitigate the effects of these conditions:3 years.
 
 
Secondary Outcome  
Outcome  TimePoints 
Contribution to poor brain & cognitive phenotype in an Indian patient cohort.  Contribution to poor brain & cognitive phenotype in an Indian patient cohort:4years 
 
Target Sample Size   Total Sample Size="20"
Sample Size from India="20" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
In postmitotic tissues with high functioning and transcriptional activity, such as the brain and skeletal muscles, maintenance of mitochondrial DNA (mtDNA) is essential for energy production. On the other hand, little is known about how mitochondrial functions in people with neurological diseases are affected by deficiencies in DNA repair. Dysfunctions in DNA repair pathways have been linked to neurodegeneration, aging, and the ability to respond to treatment interventions such as radiation therapy and chemotherapy. The goal of the proposed program is to identify the genes that cause the mutations that affect mitochondrial function and are linked to the maintenance of mitochondrial DNA in a group of Indian patients who have cognitive and cerebral impairments. It is expected that the functional analysis of pathogenic mutations will aid in the creation of disease models, improving the accuracy of diagnosis and developing treatment plans specific to the Indian populace.

 
Close